IADT

Intermittent ADT, Does It Increase A Man’s Risk Factors For Serious Side Effects?

Once again we see what seems to be logical isn’t necessarily the way it actually works! In a surprising study result, it was shown that the use of intermittent androgen-deprivation therapy (IADT) for prostate cancer is not associated with fewer long-term adverse events than continuous ADT! Who would have guessed? We all thought that intermittent [...]

By Malecare|2020-02-04T11:07:09-05:00January 21st, 2016|Advanced Prostate Cancer, Clinical Trials & Research, Drugs & Treatments, Hormone Therapy, Quality of Life, Research, Schedule, Uncategorized, Understanding Advanced Prostate Cancer|0 Comments

*Does Avodart (Dutasteride) Allow Men on Intermittent Androgen Therapy To Have A Longer “Off Period”?

Researchers performed a randomized, placebo-controlled Phase II trial of men with localized prostate cancer and a rising prostate-specific antigen (PSA) level post-primary treatment. The men were randomized to receive Avodart (dutasteride @ 0.5 mg/day) or to receive a placebo. All of the men were receiving intermittent androgen deprivation therapy (IADT), which was stopped at month [...]

By Malecare|2015-02-17T15:32:35-05:00February 17th, 2015